Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARTNER trial of patient-requested targeted therapy for pediatric and AYA solid tumors
jRCTs031230544Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jan 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial in Nonhematologic neoplasms, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Percentage of adverse events equivalent to dose-limiting toxicities in each drug cohort. Started Jan 2024; status: recruiting.
02
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCTs031230544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230544.